Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387	Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, cardiovascular disorder, heart disorder, pericarditis	Recruiting	Phase 2 / Phase 3	2026-08-26		NCT07010159

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Kiniksa Pharmaceuticals International, plc	3
Kiniksa Pharmaceuticals, GmbH	2

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials